A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

Gao, Lin-rui; Wang, Xin; Han, Weiming; Deng, Wei; Li, Chen; Wang, Xiaomin; Zhao, Yidian; Ni, Wenjie; Chang, Xiao; Zhou, Zongmei; Deng, Lei; Wang, Wenqing; Liu, Wenyang; Liang, Jun; Zhang, Tao; Bi, Nan; Wang, Jianyang; Zhai, Yirui; Feng, Qinfu; Lv, Jima; Li, Ling; Xiao, Zefen

doi:10.1186/s12885-020-07387-y

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 3:05:31 Z

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

Access & Citations

2457

Article Accesses
6

Web of Science
6

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com